Genlyte has a fast Ebola diagnostic test; CardioKinetix starts heart failure device trial in China;

@FierceMedDev: Mobile blood glucose monitor startup Telcare gets $33M round. Article | Follow @FierceMedDev

@VarunSaxena2: Sanofi leads $11M Series A round for needle-free delivery company. FierceDrugDelivery story | Follow @VarunSaxena2

@EmilyWFierce: ICYMI yesterday: U.S. Department of Homeland Security investigating cybersecurity concerns for devices from $MDT, $STJ and $HSP. More | Follow @EmilyWFierce

@MichaelGFierce: Encapsulated Alzheimer's, Parkinson's-treating growth factors implanted directly in the brain. FierceDrugDelivery article | Follow @MichaelGFierce

> San Diego-based Genalyte, a diagnostic laboratory startup, has a test capable of detecting the early stages of Ebola in the blood in as little as 10 minutes. Release

> Resonetics, a company that provides laser micromachining manufacturing services for the medical device and diagnostic industries, was acquired by private equity firm Sverica International. Release

> CardioKinetix, a medical device company developing catheter-based treatments for heart failure, enrolled the first 10 patients in China a multi-center trial to evaluate the minimally invasive Parachute Ventricular Partitioning Device heart failure treatment. Release

> The U.S. Patent and Trademark Office's patent trial board ruled in favor of Becton Dickinson ($BDX) in a case about a catheter-assembly patent held by One StockDuq Holdings. Story

Biotech News

@FierceBiotech: J&J heads to Texas with its R&D farm system, scouting for biotech startups. News | Follow @FierceBiotech

@JohnCFierce: Celgene adds $1B-plus immuno-oncology deal, buyout option for Sutro, a Fierce 15 company. News | Follow @JohnCFierce

@DamianFierce: Inbox: "FDA Encourages Juice Safety This Fall"; juice safely, everyone. | Follow @DamianFierce

@EmilyMFierce: Sigh. US midterm elections offer little hope for science. More from Nature | Follow @EmilyMFierce

> Women's health biotech Forendo raises $15M from some pharma giants. Item

> Lilly bets another $375M on Zymeworks' two-pronged cancer tech. Story

> Pfizer, Novartis chip in on $17M round for an Atlas upstart focused on pain. Article

Pharma News

@FiercePharma: Top-read in FP Wednesday: $GSK dealmaking spawns management shake-up, putting Slaoui and Hussain in top slots. Article | Follow @FiercePharma

@CarlyHFierce: Novartis drafts TV celeb Nick Cannon to talk up importance of flu vaccines. FierceVaccines item | More from FiercePharmaMarketing | Follow @CarlyHFierce

> Medicines Company sues lawyers for busting Angiomax patent filing deadline. Story

> Eli Lilly continues downward spiral in Q3 as generics slam Cymbalta, Evista sales. More

> Celgene's powerhouse Revlimid gets a little Q3 help from new friends Pomalyst, Otezla. Article

Vaccines News

> Could oral vaccines shake up the flu shot market? Vaxart's Ph I says maybe. More

> GSK taps Slaoui to chair flat-selling vaccines unit with an eye to the future. Story

> Novartis drafts TV celeb Nick Cannon to talk up importance of flu vaccines. Item

> Ebola roundup: J&J invests $200M in R&D, Glaxo says vaccine will come too late. More

> FDA accepts app for Merck, Sanofi 6-in-1 combo vaccine. Article

Pharma Manufacturing News

> Roche, too, has big plans for improved HQ facilities. Item

> Industry faces new effort to make it pay for drug disposal. More

> Repackager mistakenly puts some ibuprofen bottles into naproxen boxes. Report

> GSK manufacturing will take hit in cost-cutting move. Story

> Argos starts work on $57M plant in North Carolina. Article